National Human Genome Research Institute to Grant Exclusive Patent License to Leadiant Biosciences for N-Acetyl Mannosamine as Therapeutic Agent

Summary

The National Human Genome Research Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting Leadiant Biosciences, Inc., a biotechnology company based in Gaithersburg, Maryland, USA, an exclusive patent license to use N-Acetyl Mannosamine as a therapeutic agent, as outlined in a patent application.